knowledge -WSS

knowledge

author：explore 2025-08-04 03:41:47 - browse：297

WASHINGTON, DC - NOVEMBER 27: U.S. President Joe Biden speaks about supply chain resilience during an event in the Indian Treaty Room at the Eisenhower Executive Office Building on November 27, 2023 in Washington, DC. — President Biden spoke about supply chain resilience and drug shortages. Alex Wong/Getty Images

WASHINGTON — President Biden’s new plan to curb drug shortages by boosting domestic drug production won’t expand the supply of the chemotherapies that are currently in shortage, an administration official confirmed. The limited scope surprised experts, who told STAT Biden could have included those drugs in the effort.

The 15 cancer drugs in short supply account for only a little more than 10% of the drugs on FDA’s shortage list. But chemotherapies are far more crucial than many other drugs experiencing shortages, which include injections of amino acids and multivitamins, and sterile water. Gut-wrenching stories about cancer patients being switched to less-effective drugs have caused cancer doctors to agitate for government solutions.

Biden announced last week that he plans to use the Defense Production Act to get companies to make essential medicines and their ingredients in the United States. The administration will spend $35 million to boost domestic production of key starting materials for drugs that hospitals commonly use and are prone to shortages.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Listen: Biogen's potential pivot, & Illumina's next chapter

WSS

Crinetics acromegaly drug succeeds in late

What should King Charles tell the public about his cancer?

Biogen Alzheimer’s drug launch off to slow start

'Make People Better': The CRISPR babies story you probably don't know

Snackable artificial intelligence, expert AI, and the pharma industry

Seth Rogen and Lauren Miller Rogen on Alzheimer's caregiving

leisure time

knowledge

focus

Jerome Adams on the need for new antivirals for Covid

For Medicare Advantage, Democrats want stronger protections around AI

Virginia high school admissions case could be legal follow

Trump surgeon general acknowledges mistakes during Covid

Medical leaders decry Supreme Court decision on affirmative action

The dental labor crisis is a moment of opportunity

What does generative AI mean for health care? We asked experts

The 10 drugs up first for Medicare price negotiation

How to save PrEP access — and even expand it

How to fix cancer clinical trials' diversity problem

leisure time

A ‘polypill’ could sharply reduce cardiovascular disease in the U.S.

Industry veterans launch new biotech VC with $310M

KalVista pill reduced swelling 'attacks' caused by genetic disease

KalVista pill reduced swelling 'attacks' caused by genetic disease

Covid hospitalizations on the rise, Humana says

PhRMA lawsuit over Medicare drug price negotiation tossed

hotspot

explore

focus

leisure time